The German company validated the panel, which focuses on actionable results, in a 300-participant clinical study in collaboration with Robert-Bosch-Hospital in Stuttgart.
While a randomized-controlled trial is underway, Genomind hopes data from a new case-control study will convince insurers its PGx test can reduce healthcare utilization costs.
The company presented new data on the PGx test this week and expressed confidence that they can secure broader payor coverage for it.
The company had total revenues of $193.5 million during the quarter, driven by continued increases in revenue and test volume for its more recently launched and acquired tests.
China has been a key focus for Agena, which established a Shanghai subsidiary in 2015.
The companies will develop a platform for sample and workflow management, genetic data interpretation, and external client communication.
Under the agreement, PGS.Holland will market Bio.logis' Genetic Information Management Suite in Benelux, Scandinavia, and the UK.
Prescient said the acquisition will expand its lab capabilities and enhance its relationships with local, regional, and national health insurers.
The test analyzes clinically relevant genetic variants for 14 genes related to certain pain and mental health medication responses to help guide clinicians' prescribing decisions.
RPRD will expand the availability of its PGx testing services to South Korea, and Orient Bio will diversify its business to include precision medicine and clinical PGx.